Efficacy and Safety of Antithrombotic Therapy in Patients With Atrial Fibrillation, Recent Acute Coronary Syndrome, or Percutaneous Coronary Intervention and a History of Heart Failure: Insights From the AUGUSTUS Trial.

• Authors: Marat Fudim, Daniel M Wojdyla, John H Alexander, Shaun G Goodman, Roxana Mehran, Stephan Windecker, Ronald Aronson, Dragos Vinereanu, Sigrun Halvorsen, M Cecilia Bahit, Christopher B Granger, Renato D Lopes
• Journal: Journal of the American Heart Association (J Am Heart Assoc) Vol. 10 Issue 24 Pg. e023143 (12 21 2021) ISSN: 2047-9980 [Electronic] England
• PMID: 34873913 (Publication Type: Letter, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)

Chemical References

• Fibrinolytic Agents

Topics

• Acute Coronary Syndrome (drug therapy)
• Atrial Fibrillation (drug therapy)
• Clinical Trials as Topic
• Fibrinolytic Agents (adverse effects)
• Heart Failure (epidemiology)
• Humans
• Percutaneous Coronary Intervention (statistics & numerical data)
• Treatment Outcome